PDF herunterladen
Synlett 2009(14): 2301-2304  
DOI: 10.1055/s-0029-1217713
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Concise Asymmetric Synthesis of Antimalarial Alkaloid (+)-Febrifugine

Rui Wanga, Kai Fanga, Bing-Feng Suna, Ming-Hua Xu*a,b, Guo-Qiang Lin*a
a CAS Key Laboratory of Synthetic Chemistry of Natural Substances, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 354 Fenglin Road, Shanghai 200032, P. R. of China
Fax: +86(21)64166263; e-Mail: lingq@mail.sioc.ac.cn;
b Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, P. R. of China
Weitere Informationen

Publikationsverlauf

Received 17 April 2009
Publikationsdatum:
29. Juli 2009 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

An asymmetric total synthesis of antimalarial alkaloid (+)-febrifugine is accomplished in 23% overall yield over 14 steps from readily available starting materials. The synthesis features a SmI2-mediated reductive cross-coupling of chiral N-tert-butanesulfinyl imine with aldehyde.

Key words

antimalarial - asymmetric synthesis - febrifugine - cross-coupling

    References and Notes

  • 1a Koepfli JB. Mead JF. Brockman JA. J. Am. Chem. Soc.  1947,  69:  1837 
    Google Scholar
  • 1b Koepeli JB. Mead JF. Brockman JA. J. Am. Chem. Soc.  1949,  71:  1048 
    Google Scholar
  • 1c Ablondi F. Gordon S. Morton J. Williams JH.
    J. Org. Chem.  1952,  17:  14 
    Google Scholar
  • 1d Barringer DF. Beakelhammer GB. Carter SD. Goldman L. Lanzilotti AE. J. Org. Chem.  1973,  38:  1933 
    Google Scholar
  • 1e Barringer DF. Beakelhammer GB. Wayne RS. J. Org. Chem.  1973,  38:  1937 
    Google Scholar
  • 1f Kato M. Inaba M. Itahana H. Ohara E. Nakamura K. Uesato S. Inouye H. Fujita T. Shoyakugaku Zasshi  1990,  44:  288 
    Google Scholar
  • 2a Kobayashi S. Ueno M. Suzuki R. Ishitani H. Tetrahedron Lett.  1999,  40:  2175 
    Google Scholar
  • 2b Kobayashi S. Ueno M. Suzuki R. Ishitani H. Kim HS. Wataya Y. J. Org. Chem.  1999,  64:  6833 
    Google Scholar
  • 3a Fishman M. Cruickshank PA. J. Med. Chem.  1970,  13:  155 
    Google Scholar
  • 3b Chien P.-L. Cheng CC. J. Med. Chem.  1970,  13:  867 
    Google Scholar
  • 3c De Smet PAGM. Drugs  1997,  54:  801 
    Google Scholar
  • 4a Takeuchi Y. Abe H. Harayama T. Chem. Pharm. Bull.  1999,  47:  905 
    Google Scholar
  • 4b Takeuchi Y. Hattori M. Abe H. Harayama T. Synthesis  1999,  1814 
    Google Scholar
  • 4c Takeuchi Y. Azuma K. Takakura K. Abe H. Harayama T. Chem. Commun.  2000,  1643 
    Google Scholar
  • 4d Okitsu O. Suzuki R. Kobayashi S. Synlett  2000,  989 
    Google Scholar
  • 4e Taniguchi T. Ogasawara K. Org. Lett.  2000,  2:  3193 
    Google Scholar
  • 4f Takeuchi Y. Azuma K. Takakura K. Abe H. Kim HS. Wataya Y. Harayama T. Tetrahedron  2001,  57:  1213 
    Google Scholar
  • 4g Ooi H. Urushibara A. Esumi T. Iwabuchi Y. Hatakeyama S. Org. Lett.  2001,  3:  953 
    Google Scholar
  • 4h Sugiura M. Kobayashi S. Org. Lett.  2001,  3:  477 
    Google Scholar
  • 4i Sugiura M. Hagio H. Hirabayashi R. Kobayashi S. J. Org. Chem.  2001,  66:  809 
    Google Scholar
  • 4j Sugiura M. Hagio H. Hirabayashi R. Kobayashi S. J. Am. Chem. Soc.  2001,  123:  12510 
    Google Scholar
  • 4k Huang P.-Q. Wei BG. Ruan Y.-P. Synlett  2003,  1663 
    Google Scholar
  • 4l Katoh M. Matsune R. Nagase H. Honda T. Tetrahedron Lett.  2004,  45:  6221 
    Google Scholar
  • 4m Zhu S.-R. Meng L. Zhang Q. Wei L. Bioorg. Med. Chem. Lett.  2006,  16:  1854 
    Google Scholar
  • 4n Ashoordazeh A. Caprio V. Synlett  2005,  346 
    Google Scholar
  • 4o Katoh M. Matsune R. Honda T. Heterocycles  2006,  67:  189 
    Google Scholar
  • 4p Kikuchi H. Yamamoto K. Horoiwa S. Hirai S. Kasahara R. Hariguchi N. Matsumoto M. Oshima Y. J. Med. Chem.  2006,  49:  4698 
    Google Scholar
  • 4q Sieng B. Ventura OL. Bellosta V. Cossy J. Synlett  2008,  1216 
    Google Scholar
  • 4r Wee AGH. Fan G.-J. Org. Lett.  2008,  10:  3869 
    Google Scholar
  • 5a Zhong Y.-W. Dong Y.-Z. Fang K. Isumi K. Xu M.-H. Lin G.-Q. J. Am. Chem. Soc.  2005,  127:  11956 
    Google Scholar
  • 5b Zhong Y.-W. Xu M.-H. Lin G.-Q. Org. Lett.  2004,  6:  3953 
    Google Scholar
  • 5c Zhong Y.-W. Isumi K. Xu M.-H. Lin G.-Q. Org. Lett.  2004,  6:  4747 
    Google Scholar
  • 7 Mosset P. Pointeau P. Aubert F. Lellouche JP. Beaucourt JP. Gree R. Bull. Soc. Chem. Fr.  1990,  298 
    Google Scholar
  • 8a Huang SL. Omura K. Swern D. J. Org. Chem.  1976,  41:  3329 
    Google Scholar
  • 8b Huang SL. Omura K. Swern D. Synthesis  1978,  297 
    Google Scholar
  • 9a Liu GC. Cogan DA. Owens TD. Tang TP. Ellman JA. J. Org. Chem.  1999,  64:  1278 
    Google Scholar
  • 9b Ellman JA. Owens TD. Tang TP. Acc. Chem. Res.  2002,  35:  984 
    Google Scholar
  • 9c Huang ZY. Zhang M. Wang Y. Qin Y. Synlett  2005,  1334 
    Google Scholar
  • 10 Crich D. Smith M. J. Am. Chem. Soc.  2001,  123:  9015 
    CrossrefPubMedGoogle Scholar
  • 11 Martinelli MJ. Nayyar NK. Moher ED. Dhokte UP. Pawlak JM. Vaidyanathan R. Org. Lett.  1999,  1:  447 
    CrossrefGoogle Scholar
  • 12 Clink RD. Forsyth C. J. Org. Chem.  1995,  60:  8122 
    CrossrefGoogle Scholar
  • 13 Cruickshank PA. Fishman M. J. Org. Chem.  1969,  34:  3060 
    Google Scholar
  • 14 Dess DB. Martin JC. J. Org. Chem.  1983,  48:  4155 
    CrossrefGoogle Scholar
6

Indeed, a preliminary study, which utilized aldehyde A and imine B (Scheme  [6] ) as the substrates to investigate the impact of a stereocenter adjacent to the reaction site, has established that the N-sulfinyl group determines the stereochemistry of the product C, whose structure was confirmed by X-ray crystallography (CCDC deposit no. 724597). These data can be obtained free of charge from
The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.

Scheme 6

15

Selected Experiment and Spectroscopic DataPreparation of Compound 4
To the solution of SmI2 (4.0 mmol in 20 mL of THF) the solution of imine 5 (480 mg, 1.90 mmol), aldehyde 6 (1.14 g, 3.80 mmol) and t-BuOH (380 µL, 4.0 mmol) in 20 mL of THF was dropped in slowly under argon at -78 ˚C.
The mixture was stirred vigorously for 7 h at the same temperature and then quenched by 10 mL sat. Na2S2O3 aq solution. The organic layer was separated, and the aqueous layer was extracted with EtOAc. The combined organic extracts were washed by sat. brine and then dried over anhyd MgSO4, filtered, and concentrated under vacuum. After flash silica gel chromatography, 952 mg (85%) of the pure product 4 was obtained as yellow oil.
Compound 4: [α]D ²8 +33.0 (c 2.70, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 7.65 (d, J = 6.9 Hz, 4 H), 7.45-7.26 (m, 6 H), 4.46 (d, J = 4.8 Hz, 1 H), 4.29 (m, 1 H), 4.12 (dd, J = 8.1, 5.7 Hz, 1 H), 3.74-3.67 (m, 3 H), 3.52 (t, J = 7.8 Hz, 1 H), 3.42 (m, 1 H), 3.05 (d, J = 4.8 Hz, 1 H), 1.89-1.52 (m, 6 H), 1.40 (s, 3 H), 1.36 (s, 3 H), 1.24 (s, 9 H), 1.05 (s, 9 H). ¹³C NMR (75 MHz, CDCl3): δ = 135.48, 133.67, 129.55, 127.57, 109.57, 73.65, 72.59, 69.65, 63.79, 57.96, 55.57, 32.16, 29.77, 29.14, 26.83, 26.79, 25.73, 22.62, 19.11. FT-IR (thin film): 3414, 3283, 2983, 2959, 2933, 2860, 1112, 1052 cm-¹. ESI-MS: m/z = 576.3 [M + H]+, 598.3 [M + Na]+. MALDI-HRMS: m/z calcd for C31H49NO5SSiNa [M + Na]+: 598.2993; found: 598.3011.
Compound 14: [α]D ²5 +64.6 (c 0.60, CHCl3). ¹H NMR (400 MHz, CDCl3): δ = 8.26 (m, 1 H), 7.98 (s, 1 H), 7.81-7.73 (m, 2 H), 7.51 (m, 1 H), 7.32-7.24 (m, 5 H), 4.96 (d, J = 17.6 Hz, 1 H), 4.75 (d, J = 17.6 Hz, 1 H), 4.63-4.52 (m, 2 H), 4.42 (s, 1 H), 3.62-3.59 (m, 2 H), 3.11-3.03 (m, 2 H), 2.75 (m, 1 H), 2.05-1.92 (m, 2 H), 1.62-1.47 (m, 2 H), 1.38-1.33 (m, 9 H). ¹³C NMR (100 MHz, CDCl3): δ = 200.67, 160.95, 148.33, 146.60, 138.18, 134.44, 128.26, 127.70, 127.61, 127.54, 127.29, 126.67, 121.86, 74.29, 70.81, 61.98, 54.80, 54.70, 43.16, 42.05, 24.10, 23.24, 19.62. FT-IR (thin film): 2928, 2870, 1308, 936 cm-¹. ESI-MS: m/z = 512.4 [M + H]+, 534.4 [M + Na]+. ESI-HRMS: m/z calcd for C27H34N3O5S [M + H]+: 512.2214; found: 512.2232.
Compound 1: mp 137-139 ˚C; [α]D ²6 +27.3 (c 0.45, EtOH) [lit.¹b mp 139-140 ˚C; [α]D ²5 +28.0 (c 0.5, EtOH)]. ¹H NMR (500 MHz, CDCl3): δ = 8.28 (m, 1 H), 7.89 (s, 1 H), 7.77-7.72 (m, 2 H), 7.52 (t, J = 6.7 Hz, 1 H), 4.90 (d, J = 17.7 Hz, 1 H), 4.81 (d, J = 17.7 Hz, 1 H), 3.28 (br s, 1 H), 3.11 (dd, J = 15.9, 3.9 Hz, 1 H), 2.96 (d, J = 11.0 Hz, 1 H), 2.87 (br d, J = 3.9 Hz, 1 H), 2.65 (dd, J = 15.9, 6.7 Hz, 1 H), 2.58 (m, 1 H), 2.08 (br d, J = 10.7 Hz, 1 H), 1.84 (br, 2 H), 1.70 (br d, J = 12.4 Hz, 1 H), 1.52 (br d, J = 12.8 Hz, 1 H), 1.34 (br d, J = 10.1 Hz, 1 H). ¹³C NMR (125 MHz, CDCl3): δ = 202.64, 161.01, 148.23, 146.39, 134.54, 127.64, 127.44, 126.80, 121.88, 72.26, 60.18, 54.85, 45.97, 44.04, 34.48, 25.65. FT-IR (thin film): 3304, 3287, 2941, 2931, 2858, 2814, 1722, 1674, 1614, 1475, 1363, 1084, 773, 698 cm-¹. ESI-MS: m/z = 302.2 [M + H]+, 324.2 [M + Na]+. ESI-HRMS: m/z calcd for C16H20N3O3 [M + H]+: 302.1500; found: 302.1499.